Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-09T12:22:08.661Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of Methylhydrazine in the treatment of Hodgkin's disease

Published online by Cambridge University Press:  01 August 2014

P. Introzzi  and
G. Marinone
P. Introzzi
Affiliation:
Istituto di Clinica Medica dell'Università di Pavia
G. Marinone
Affiliation:
Istituto di Clinica Medica dell'Università di Pavia

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Authors analyse the action of MH on the chromosomes of normal myeloid cells. They evaluate the indications, therapeutic activity and the limits of this substance on Hodgkin disease.

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 17 , Issue 1 , January 1968 , pp. 171 - 177
Copyright
Copyright © The International Society for Twin Studies 1968

References

Bibliographie

Baserga, A., Marinone, G. (1949). Megamyeloid cells and aminopterin. Lancet, 257: 1056.CrossRefGoogle Scholar
Bollag, W., Grünberg, G. (1963). Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives. Experientia, 19: 129.CrossRefGoogle ScholarPubMed
Casertano, F., Robustelli Della Cuna, G. (1966). Sopra un carattere meno noto dell'azione della metilidrazina sulle cellule midollari: la formazione di cellule megamieloidi. Haemat., 51: 181.Google Scholar
Garces, B., Sanz Anton, J. (1964). Accion farmacologica del citostatico Ro 4-6467. Arch. Inst. Farmacol. Exper., 16: 45.Google Scholar
Introzzi, P., Marinone, G. (1966). La posizione di una metilidrazina nel trattamento del granuloma maligno dopo due anni di esperienza clinica. Minerva Med., 57: 1133.Google Scholar
Robustelli Della Cuna, G., Marini, G. Recherches inédites.Google Scholar